nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—TNF—asthma	0.193	0.678	CbGaD
Thalidomide—PTGS2—asthma	0.0917	0.322	CbGaD
Thalidomide—PTGS1—Zileuton—asthma	0.026	0.0647	CbGbCtD
Thalidomide—CYP1A1—Isoprenaline—asthma	0.0248	0.0617	CbGbCtD
Thalidomide—PTGS1—Zafirlukast—asthma	0.0229	0.0569	CbGbCtD
Thalidomide—CYP2E1—Zafirlukast—asthma	0.0177	0.044	CbGbCtD
Thalidomide—CYP1A1—Theophylline—asthma	0.0177	0.044	CbGbCtD
Thalidomide—CYP3A5—Beclomethasone—asthma	0.0175	0.0435	CbGbCtD
Thalidomide—CYP3A5—Salmeterol—asthma	0.0175	0.0435	CbGbCtD
Thalidomide—PTGS1—Montelukast—asthma	0.0168	0.0417	CbGbCtD
Thalidomide—CYP3A5—Fluticasone Propionate—asthma	0.0149	0.037	CbGbCtD
Thalidomide—CYP2E1—Aminophylline—asthma	0.0145	0.0361	CbGbCtD
Thalidomide—PTGS2—Triamcinolone—asthma	0.0138	0.0342	CbGbCtD
Thalidomide—CYP2E1—Theophylline—asthma	0.0137	0.034	CbGbCtD
Thalidomide—PTGS2—Betamethasone—asthma	0.0118	0.0293	CbGbCtD
Thalidomide—CYP1A2—Zileuton—asthma	0.0116	0.0289	CbGbCtD
Thalidomide—CYP2C19—Zafirlukast—asthma	0.0111	0.0276	CbGbCtD
Thalidomide—CYP2C19—Arformoterol—asthma	0.0107	0.0266	CbGbCtD
Thalidomide—CYP2C19—Formoterol—asthma	0.0107	0.0266	CbGbCtD
Thalidomide—CYP2C9—Zileuton—asthma	0.0105	0.026	CbGbCtD
Thalidomide—CYP1A2—Zafirlukast—asthma	0.0102	0.0254	CbGbCtD
Thalidomide—CYP2C9—Zafirlukast—asthma	0.00922	0.0229	CbGbCtD
Thalidomide—CYP2C9—Arformoterol—asthma	0.00891	0.0221	CbGbCtD
Thalidomide—CYP2C9—Formoterol—asthma	0.00891	0.0221	CbGbCtD
Thalidomide—CYP1A2—Aminophylline—asthma	0.0084	0.0209	CbGbCtD
Thalidomide—CYP2C19—Loratadine—asthma	0.00812	0.0202	CbGbCtD
Thalidomide—CYP1A2—Theophylline—asthma	0.0079	0.0196	CbGbCtD
Thalidomide—CYP2C9—Theophylline—asthma	0.00712	0.0177	CbGbCtD
Thalidomide—PTGS2—Dexamethasone—asthma	0.00687	0.0171	CbGbCtD
Thalidomide—CYP2C9—Loratadine—asthma	0.00675	0.0168	CbGbCtD
Thalidomide—CYP2C9—Montelukast—asthma	0.00675	0.0168	CbGbCtD
Thalidomide—CYP1A1—Dexamethasone—asthma	0.0058	0.0144	CbGbCtD
Thalidomide—CYP3A5—Hydrocortisone—asthma	0.0056	0.0139	CbGbCtD
Thalidomide—CYP2C19—Prednisone—asthma	0.0045	0.0112	CbGbCtD
Thalidomide—CYP2E1—Dexamethasone—asthma	0.00448	0.0111	CbGbCtD
Thalidomide—CYP3A5—Dexamethasone—asthma	0.00348	0.00865	CbGbCtD
Thalidomide—CYP2C19—Dexamethasone—asthma	0.00281	0.00698	CbGbCtD
Thalidomide—FGFR2—exocrine gland—asthma	0.00254	0.0768	CbGeAlD
Thalidomide—CYP2C9—Dexamethasone—asthma	0.00233	0.0058	CbGbCtD
Thalidomide—NFKB1—respiratory system—asthma	0.00176	0.0532	CbGeAlD
Thalidomide—CRBN—respiratory system—asthma	0.00148	0.0446	CbGeAlD
Thalidomide—NFKB1—bronchus—asthma	0.00145	0.0438	CbGeAlD
Thalidomide—NFKB1—cardiovascular system—asthma	0.00135	0.0408	CbGeAlD
Thalidomide—FGFR2—respiratory system—asthma	0.00132	0.04	CbGeAlD
Thalidomide—NFKB1—trachea—asthma	0.0013	0.0393	CbGeAlD
Thalidomide—CRBN—adrenal cortex—asthma	0.00124	0.0374	CbGeAlD
Thalidomide—CRBN—bronchus—asthma	0.00122	0.0367	CbGeAlD
Thalidomide—Menadione—BGLAP—asthma	0.00111	0.321	CrCbGaD
Thalidomide—FGFR2—epithelium—asthma	0.00111	0.0334	CbGeAlD
Thalidomide—CRBN—trachea—asthma	0.00109	0.033	CbGeAlD
Thalidomide—NFKB1—adrenal gland—asthma	0.00107	0.0322	CbGeAlD
Thalidomide—FGFR2—smooth muscle tissue—asthma	0.00107	0.0322	CbGeAlD
Thalidomide—FGFR2—cardiovascular system—asthma	0.00101	0.0306	CbGeAlD
Thalidomide—NFKB1—lung—asthma	0.000936	0.0283	CbGeAlD
Thalidomide—CRBN—adrenal gland—asthma	0.000895	0.027	CbGeAlD
Thalidomide—Pomalidomide—TNF—asthma	0.000806	0.233	CrCbGaD
Thalidomide—FGFR2—adrenal gland—asthma	0.000802	0.0242	CbGeAlD
Thalidomide—CRBN—lung—asthma	0.000784	0.0237	CbGeAlD
Thalidomide—Menadione—NQO1—asthma	0.000751	0.217	CrCbGaD
Thalidomide—FGFR2—lung—asthma	0.000703	0.0212	CbGeAlD
Thalidomide—CYP1A2—respiratory system—asthma	0.000486	0.0147	CbGeAlD
Thalidomide—CYP1A1—respiratory system—asthma	0.000479	0.0145	CbGeAlD
Thalidomide—CYP3A5—respiratory system—asthma	0.000468	0.0141	CbGeAlD
Thalidomide—CYP2E1—respiratory system—asthma	0.000437	0.0132	CbGeAlD
Thalidomide—PTGS1—respiratory system—asthma	0.000421	0.0127	CbGeAlD
Thalidomide—Lenalidomide—PTGS2—asthma	0.000412	0.119	CrCbGaD
Thalidomide—PTGS2—respiratory system—asthma	0.000402	0.0121	CbGeAlD
Thalidomide—CYP1A1—epithelium—asthma	0.0004	0.0121	CbGeAlD
Thalidomide—CYP1A1—bronchus—asthma	0.000394	0.0119	CbGeAlD
Thalidomide—Pomalidomide—PTGS2—asthma	0.000383	0.111	CrCbGaD
Thalidomide—CYP1A1—trachea—asthma	0.000354	0.0107	CbGeAlD
Thalidomide—CYP2C9—cardiovascular system—asthma	0.000353	0.0107	CbGeAlD
Thalidomide—PTGS1—epithelium—asthma	0.000352	0.0106	CbGeAlD
Thalidomide—PTGS1—smooth muscle tissue—asthma	0.000339	0.0102	CbGeAlD
Thalidomide—PTGS2—adrenal cortex—asthma	0.000338	0.0102	CbGeAlD
Thalidomide—PTGS2—epithelium—asthma	0.000336	0.0102	CbGeAlD
Thalidomide—CYP2E1—cardiovascular system—asthma	0.000335	0.0101	CbGeAlD
Thalidomide—PTGS2—bronchus—asthma	0.000331	0.01	CbGeAlD
Thalidomide—PTGS2—smooth muscle tissue—asthma	0.000324	0.00978	CbGeAlD
Thalidomide—PTGS1—cardiovascular system—asthma	0.000322	0.00974	CbGeAlD
Thalidomide—PTGS1—trachea—asthma	0.000311	0.00939	CbGeAlD
Thalidomide—PTGS2—cardiovascular system—asthma	0.000308	0.00931	CbGeAlD
Thalidomide—PTGS2—Fluocinonide—Ciclesonide—asthma	0.000298	0.111	CbGdCrCtD
Thalidomide—PTGS2—trachea—asthma	0.000297	0.00898	CbGeAlD
Thalidomide—PTGS2—Fluocinonide—Fluticasone furoate—asthma	0.000292	0.109	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Fluticasone Propionate—asthma	0.000273	0.101	CbGdCrCtD
Thalidomide—CYP2E1—adrenal gland—asthma	0.000265	0.00799	CbGeAlD
Thalidomide—CYP1A2—lung—asthma	0.000258	0.00779	CbGeAlD
Thalidomide—PTGS1—adrenal gland—asthma	0.000255	0.0077	CbGeAlD
Thalidomide—CYP1A1—lung—asthma	0.000254	0.00768	CbGeAlD
Thalidomide—CYP3A5—lung—asthma	0.000249	0.00751	CbGeAlD
Thalidomide—PTGS2—adrenal gland—asthma	0.000244	0.00736	CbGeAlD
Thalidomide—CYP2E1—lung—asthma	0.000232	0.00701	CbGeAlD
Thalidomide—PTGS1—lung—asthma	0.000223	0.00675	CbGeAlD
Thalidomide—PTGS2—lung—asthma	0.000214	0.00645	CbGeAlD
Thalidomide—PTGS2—Fluocinonide—Beclomethasone—asthma	0.0002	0.0745	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Budesonide—asthma	0.000192	0.0714	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Flunisolide—asthma	0.00019	0.0705	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Fluticasone furoate—asthma	0.000176	0.0656	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Mometasone—asthma	0.000155	0.0577	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Beclomethasone—asthma	0.000121	0.0449	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Flunisolide—asthma	0.000114	0.0425	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Mometasone—asthma	9.37e-05	0.0348	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Methylprednisolone—asthma	9.28e-05	0.0345	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Betamethasone—asthma	9.13e-05	0.0339	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Dexamethasone—asthma	9.13e-05	0.0339	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Triamcinolone—asthma	8.92e-05	0.0332	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—asthma	5.6e-05	0.0208	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Betamethasone—asthma	5.51e-05	0.0205	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—asthma	5.51e-05	0.0205	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—asthma	5.38e-05	0.02	CbGdCrCtD
Thalidomide—Oedema—Prednisolone—asthma	2.21e-05	0.000134	CcSEcCtD
Thalidomide—Loss of consciousness—Triamcinolone—asthma	2.19e-05	0.000133	CcSEcCtD
Thalidomide—Loss of consciousness—Methylprednisolone—asthma	2.18e-05	0.000132	CcSEcCtD
Thalidomide—Shock—Prednisolone—asthma	2.17e-05	0.000132	CcSEcCtD
Thalidomide—Cough—Triamcinolone—asthma	2.17e-05	0.000132	CcSEcCtD
Thalidomide—Oedema—Hydrocortisone—asthma	2.16e-05	0.000131	CcSEcCtD
Thalidomide—Convulsion—Triamcinolone—asthma	2.15e-05	0.000131	CcSEcCtD
Thalidomide—Tachycardia—Prednisolone—asthma	2.15e-05	0.000131	CcSEcCtD
Thalidomide—Convulsion—Methylprednisolone—asthma	2.15e-05	0.00013	CcSEcCtD
Thalidomide—Hypertension—Triamcinolone—asthma	2.15e-05	0.00013	CcSEcCtD
Thalidomide—Hypertension—Methylprednisolone—asthma	2.14e-05	0.00013	CcSEcCtD
Thalidomide—Infection—Hydrocortisone—asthma	2.14e-05	0.00013	CcSEcCtD
Thalidomide—Hyperhidrosis—Prednisolone—asthma	2.13e-05	0.000129	CcSEcCtD
Thalidomide—Shock—Hydrocortisone—asthma	2.12e-05	0.000129	CcSEcCtD
Thalidomide—Myalgia—Triamcinolone—asthma	2.12e-05	0.000129	CcSEcCtD
Thalidomide—Nervous system disorder—Hydrocortisone—asthma	2.11e-05	0.000128	CcSEcCtD
Thalidomide—Myalgia—Methylprednisolone—asthma	2.11e-05	0.000128	CcSEcCtD
Thalidomide—Arthralgia—Methylprednisolone—asthma	2.11e-05	0.000128	CcSEcCtD
Thalidomide—Eye disorder—Prednisone—asthma	2.11e-05	0.000128	CcSEcCtD
Thalidomide—Anxiety—Methylprednisolone—asthma	2.1e-05	0.000128	CcSEcCtD
Thalidomide—Tachycardia—Hydrocortisone—asthma	2.1e-05	0.000128	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.1e-05	0.000127	CcSEcCtD
Thalidomide—Skin disorder—Hydrocortisone—asthma	2.09e-05	0.000127	CcSEcCtD
Thalidomide—Ill-defined disorder—Betamethasone—asthma	2.09e-05	0.000127	CcSEcCtD
Thalidomide—Ill-defined disorder—Dexamethasone—asthma	2.09e-05	0.000127	CcSEcCtD
Thalidomide—Discomfort—Triamcinolone—asthma	2.09e-05	0.000127	CcSEcCtD
Thalidomide—Discomfort—Methylprednisolone—asthma	2.09e-05	0.000127	CcSEcCtD
Thalidomide—Hyperhidrosis—Hydrocortisone—asthma	2.08e-05	0.000126	CcSEcCtD
Thalidomide—Dry mouth—Triamcinolone—asthma	2.07e-05	0.000126	CcSEcCtD
Thalidomide—Angioedema—Dexamethasone—asthma	2.06e-05	0.000125	CcSEcCtD
Thalidomide—Angioedema—Betamethasone—asthma	2.06e-05	0.000125	CcSEcCtD
Thalidomide—Anorexia—Hydrocortisone—asthma	2.05e-05	0.000125	CcSEcCtD
Thalidomide—Angiopathy—Prednisone—asthma	2.05e-05	0.000124	CcSEcCtD
Thalidomide—Confusional state—Methylprednisolone—asthma	2.04e-05	0.000124	CcSEcCtD
Thalidomide—Immune system disorder—Prednisone—asthma	2.04e-05	0.000124	CcSEcCtD
Thalidomide—Malaise—Betamethasone—asthma	2.03e-05	0.000124	CcSEcCtD
Thalidomide—Malaise—Dexamethasone—asthma	2.03e-05	0.000124	CcSEcCtD
Thalidomide—Oedema—Triamcinolone—asthma	2.03e-05	0.000123	CcSEcCtD
Thalidomide—Vertigo—Dexamethasone—asthma	2.03e-05	0.000123	CcSEcCtD
Thalidomide—Vertigo—Betamethasone—asthma	2.03e-05	0.000123	CcSEcCtD
Thalidomide—Syncope—Betamethasone—asthma	2.02e-05	0.000123	CcSEcCtD
Thalidomide—Syncope—Dexamethasone—asthma	2.02e-05	0.000123	CcSEcCtD
Thalidomide—Arrhythmia—Prednisone—asthma	2.02e-05	0.000122	CcSEcCtD
Thalidomide—Infection—Triamcinolone—asthma	2.02e-05	0.000122	CcSEcCtD
Thalidomide—Hypotension—Hydrocortisone—asthma	2.01e-05	0.000122	CcSEcCtD
Thalidomide—Infection—Methylprednisolone—asthma	2.01e-05	0.000122	CcSEcCtD
Thalidomide—Shock—Triamcinolone—asthma	2e-05	0.000121	CcSEcCtD
Thalidomide—Insomnia—Prednisolone—asthma	2e-05	0.000121	CcSEcCtD
Thalidomide—Alopecia—Prednisone—asthma	1.99e-05	0.000121	CcSEcCtD
Thalidomide—Shock—Methylprednisolone—asthma	1.99e-05	0.000121	CcSEcCtD
Thalidomide—Nervous system disorder—Methylprednisolone—asthma	1.99e-05	0.000121	CcSEcCtD
Thalidomide—Loss of consciousness—Betamethasone—asthma	1.98e-05	0.00012	CcSEcCtD
Thalidomide—Loss of consciousness—Dexamethasone—asthma	1.98e-05	0.00012	CcSEcCtD
Thalidomide—Paraesthesia—Prednisolone—asthma	1.98e-05	0.00012	CcSEcCtD
Thalidomide—Tachycardia—Triamcinolone—asthma	1.98e-05	0.00012	CcSEcCtD
Thalidomide—Mental disorder—Prednisone—asthma	1.98e-05	0.00012	CcSEcCtD
Thalidomide—Tachycardia—Methylprednisolone—asthma	1.98e-05	0.00012	CcSEcCtD
Thalidomide—Skin disorder—Methylprednisolone—asthma	1.97e-05	0.000119	CcSEcCtD
Thalidomide—Malnutrition—Prednisone—asthma	1.96e-05	0.000119	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Hydrocortisone—asthma	1.96e-05	0.000119	CcSEcCtD
Thalidomide—Hyperhidrosis—Triamcinolone—asthma	1.96e-05	0.000119	CcSEcCtD
Thalidomide—Hyperhidrosis—Methylprednisolone—asthma	1.96e-05	0.000119	CcSEcCtD
Thalidomide—Convulsion—Betamethasone—asthma	1.95e-05	0.000119	CcSEcCtD
Thalidomide—Convulsion—Dexamethasone—asthma	1.95e-05	0.000119	CcSEcCtD
Thalidomide—Insomnia—Hydrocortisone—asthma	1.95e-05	0.000118	CcSEcCtD
Thalidomide—Hypertension—Betamethasone—asthma	1.95e-05	0.000118	CcSEcCtD
Thalidomide—Hypertension—Dexamethasone—asthma	1.95e-05	0.000118	CcSEcCtD
Thalidomide—Paraesthesia—Hydrocortisone—asthma	1.94e-05	0.000117	CcSEcCtD
Thalidomide—Myalgia—Dexamethasone—asthma	1.92e-05	0.000117	CcSEcCtD
Thalidomide—Myalgia—Betamethasone—asthma	1.92e-05	0.000117	CcSEcCtD
Thalidomide—Anxiety—Betamethasone—asthma	1.91e-05	0.000116	CcSEcCtD
Thalidomide—Anxiety—Dexamethasone—asthma	1.91e-05	0.000116	CcSEcCtD
Thalidomide—Discomfort—Betamethasone—asthma	1.9e-05	0.000115	CcSEcCtD
Thalidomide—Discomfort—Dexamethasone—asthma	1.9e-05	0.000115	CcSEcCtD
Thalidomide—Dyspepsia—Hydrocortisone—asthma	1.9e-05	0.000115	CcSEcCtD
Thalidomide—Hypotension—Methylprednisolone—asthma	1.89e-05	0.000115	CcSEcCtD
Thalidomide—Pain—Prednisolone—asthma	1.89e-05	0.000115	CcSEcCtD
Thalidomide—Decreased appetite—Hydrocortisone—asthma	1.87e-05	0.000114	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Hydrocortisone—asthma	1.86e-05	0.000113	CcSEcCtD
Thalidomide—Fatigue—Hydrocortisone—asthma	1.86e-05	0.000113	CcSEcCtD
Thalidomide—Vision blurred—Prednisone—asthma	1.85e-05	0.000112	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Triamcinolone—asthma	1.85e-05	0.000112	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Methylprednisolone—asthma	1.84e-05	0.000112	CcSEcCtD
Thalidomide—Pain—Hydrocortisone—asthma	1.84e-05	0.000112	CcSEcCtD
Thalidomide—Oedema—Dexamethasone—asthma	1.84e-05	0.000112	CcSEcCtD
Thalidomide—Oedema—Betamethasone—asthma	1.84e-05	0.000112	CcSEcCtD
Thalidomide—Insomnia—Triamcinolone—asthma	1.84e-05	0.000111	CcSEcCtD
Thalidomide—Insomnia—Methylprednisolone—asthma	1.83e-05	0.000111	CcSEcCtD
Thalidomide—Infection—Dexamethasone—asthma	1.83e-05	0.000111	CcSEcCtD
Thalidomide—Infection—Betamethasone—asthma	1.83e-05	0.000111	CcSEcCtD
Thalidomide—Ill-defined disorder—Prednisone—asthma	1.82e-05	0.000111	CcSEcCtD
Thalidomide—Paraesthesia—Triamcinolone—asthma	1.82e-05	0.000111	CcSEcCtD
Thalidomide—Feeling abnormal—Prednisolone—asthma	1.82e-05	0.00011	CcSEcCtD
Thalidomide—Paraesthesia—Methylprednisolone—asthma	1.82e-05	0.00011	CcSEcCtD
Thalidomide—Anaemia—Prednisone—asthma	1.82e-05	0.00011	CcSEcCtD
Thalidomide—Shock—Dexamethasone—asthma	1.81e-05	0.00011	CcSEcCtD
Thalidomide—Shock—Betamethasone—asthma	1.81e-05	0.00011	CcSEcCtD
Thalidomide—Dyspnoea—Triamcinolone—asthma	1.81e-05	0.00011	CcSEcCtD
Thalidomide—Nervous system disorder—Betamethasone—asthma	1.81e-05	0.00011	CcSEcCtD
Thalidomide—Nervous system disorder—Dexamethasone—asthma	1.81e-05	0.00011	CcSEcCtD
Thalidomide—Agitation—Prednisone—asthma	1.81e-05	0.00011	CcSEcCtD
Thalidomide—Thrombocytopenia—Betamethasone—asthma	1.8e-05	0.000109	CcSEcCtD
Thalidomide—Thrombocytopenia—Dexamethasone—asthma	1.8e-05	0.000109	CcSEcCtD
Thalidomide—Tachycardia—Dexamethasone—asthma	1.8e-05	0.000109	CcSEcCtD
Thalidomide—Tachycardia—Betamethasone—asthma	1.8e-05	0.000109	CcSEcCtD
Thalidomide—Angioedema—Prednisone—asthma	1.8e-05	0.000109	CcSEcCtD
Thalidomide—Dyspepsia—Triamcinolone—asthma	1.79e-05	0.000108	CcSEcCtD
Thalidomide—Dyspepsia—Methylprednisolone—asthma	1.78e-05	0.000108	CcSEcCtD
Thalidomide—Hyperhidrosis—Dexamethasone—asthma	1.78e-05	0.000108	CcSEcCtD
Thalidomide—Hyperhidrosis—Betamethasone—asthma	1.78e-05	0.000108	CcSEcCtD
Thalidomide—Feeling abnormal—Hydrocortisone—asthma	1.78e-05	0.000108	CcSEcCtD
Thalidomide—Malaise—Prednisone—asthma	1.77e-05	0.000108	CcSEcCtD
Thalidomide—Vertigo—Prednisone—asthma	1.77e-05	0.000107	CcSEcCtD
Thalidomide—Gastrointestinal pain—Hydrocortisone—asthma	1.76e-05	0.000107	CcSEcCtD
Thalidomide—Syncope—Prednisone—asthma	1.76e-05	0.000107	CcSEcCtD
Thalidomide—Anorexia—Dexamethasone—asthma	1.76e-05	0.000107	CcSEcCtD
Thalidomide—Anorexia—Betamethasone—asthma	1.76e-05	0.000107	CcSEcCtD
Thalidomide—Urticaria—Prednisolone—asthma	1.75e-05	0.000106	CcSEcCtD
Thalidomide—Fatigue—Triamcinolone—asthma	1.75e-05	0.000106	CcSEcCtD
Thalidomide—Fatigue—Methylprednisolone—asthma	1.75e-05	0.000106	CcSEcCtD
Thalidomide—Pain—Triamcinolone—asthma	1.74e-05	0.000105	CcSEcCtD
Thalidomide—Loss of consciousness—Prednisone—asthma	1.73e-05	0.000105	CcSEcCtD
Thalidomide—Hypotension—Betamethasone—asthma	1.72e-05	0.000104	CcSEcCtD
Thalidomide—Hypotension—Dexamethasone—asthma	1.72e-05	0.000104	CcSEcCtD
Thalidomide—Urticaria—Hydrocortisone—asthma	1.71e-05	0.000104	CcSEcCtD
Thalidomide—Abdominal pain—Hydrocortisone—asthma	1.7e-05	0.000103	CcSEcCtD
Thalidomide—Body temperature increased—Hydrocortisone—asthma	1.7e-05	0.000103	CcSEcCtD
Thalidomide—Convulsion—Prednisone—asthma	1.7e-05	0.000103	CcSEcCtD
Thalidomide—Hypertension—Prednisone—asthma	1.7e-05	0.000103	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Dexamethasone—asthma	1.68e-05	0.000102	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Betamethasone—asthma	1.68e-05	0.000102	CcSEcCtD
Thalidomide—Myalgia—Prednisone—asthma	1.67e-05	0.000102	CcSEcCtD
Thalidomide—Arthralgia—Prednisone—asthma	1.67e-05	0.000102	CcSEcCtD
Thalidomide—Feeling abnormal—Triamcinolone—asthma	1.67e-05	0.000102	CcSEcCtD
Thalidomide—Feeling abnormal—Methylprednisolone—asthma	1.67e-05	0.000101	CcSEcCtD
Thalidomide—Anxiety—Prednisone—asthma	1.67e-05	0.000101	CcSEcCtD
Thalidomide—Insomnia—Betamethasone—asthma	1.67e-05	0.000101	CcSEcCtD
Thalidomide—Insomnia—Dexamethasone—asthma	1.67e-05	0.000101	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.66e-05	0.000101	CcSEcCtD
Thalidomide—Gastrointestinal pain—Methylprednisolone—asthma	1.66e-05	0.000101	CcSEcCtD
Thalidomide—Paraesthesia—Betamethasone—asthma	1.65e-05	0.0001	CcSEcCtD
Thalidomide—Paraesthesia—Dexamethasone—asthma	1.65e-05	0.0001	CcSEcCtD
Thalidomide—Discomfort—Prednisone—asthma	1.65e-05	0.0001	CcSEcCtD
Thalidomide—Hypersensitivity—Prednisolone—asthma	1.63e-05	9.87e-05	CcSEcCtD
Thalidomide—Dyspepsia—Betamethasone—asthma	1.62e-05	9.84e-05	CcSEcCtD
Thalidomide—Dyspepsia—Dexamethasone—asthma	1.62e-05	9.84e-05	CcSEcCtD
Thalidomide—Urticaria—Triamcinolone—asthma	1.61e-05	9.79e-05	CcSEcCtD
Thalidomide—Urticaria—Methylprednisolone—asthma	1.61e-05	9.76e-05	CcSEcCtD
Thalidomide—Body temperature increased—Triamcinolone—asthma	1.6e-05	9.74e-05	CcSEcCtD
Thalidomide—Oedema—Prednisone—asthma	1.6e-05	9.73e-05	CcSEcCtD
Thalidomide—Abdominal pain—Methylprednisolone—asthma	1.6e-05	9.72e-05	CcSEcCtD
Thalidomide—Decreased appetite—Dexamethasone—asthma	1.6e-05	9.72e-05	CcSEcCtD
Thalidomide—Decreased appetite—Betamethasone—asthma	1.6e-05	9.72e-05	CcSEcCtD
Thalidomide—Infection—Prednisone—asthma	1.59e-05	9.67e-05	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Betamethasone—asthma	1.59e-05	9.65e-05	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Dexamethasone—asthma	1.59e-05	9.65e-05	CcSEcCtD
Thalidomide—Hypersensitivity—Hydrocortisone—asthma	1.59e-05	9.64e-05	CcSEcCtD
Thalidomide—Fatigue—Betamethasone—asthma	1.59e-05	9.64e-05	CcSEcCtD
Thalidomide—Fatigue—Dexamethasone—asthma	1.59e-05	9.64e-05	CcSEcCtD
Thalidomide—Shock—Prednisone—asthma	1.58e-05	9.58e-05	CcSEcCtD
Thalidomide—Pain—Dexamethasone—asthma	1.57e-05	9.56e-05	CcSEcCtD
Thalidomide—Pain—Betamethasone—asthma	1.57e-05	9.56e-05	CcSEcCtD
Thalidomide—Nervous system disorder—Prednisone—asthma	1.57e-05	9.55e-05	CcSEcCtD
Thalidomide—Tachycardia—Prednisone—asthma	1.57e-05	9.5e-05	CcSEcCtD
Thalidomide—Skin disorder—Prednisone—asthma	1.56e-05	9.45e-05	CcSEcCtD
Thalidomide—Hyperhidrosis—Prednisone—asthma	1.55e-05	9.41e-05	CcSEcCtD
Thalidomide—Asthenia—Hydrocortisone—asthma	1.55e-05	9.39e-05	CcSEcCtD
Thalidomide—Anorexia—Prednisone—asthma	1.53e-05	9.28e-05	CcSEcCtD
Thalidomide—Pruritus—Hydrocortisone—asthma	1.52e-05	9.26e-05	CcSEcCtD
Thalidomide—Feeling abnormal—Betamethasone—asthma	1.52e-05	9.21e-05	CcSEcCtD
Thalidomide—Feeling abnormal—Dexamethasone—asthma	1.52e-05	9.21e-05	CcSEcCtD
Thalidomide—Gastrointestinal pain—Dexamethasone—asthma	1.51e-05	9.14e-05	CcSEcCtD
Thalidomide—Gastrointestinal pain—Betamethasone—asthma	1.51e-05	9.14e-05	CcSEcCtD
Thalidomide—Hypersensitivity—Triamcinolone—asthma	1.5e-05	9.08e-05	CcSEcCtD
Thalidomide—Hypersensitivity—Methylprednisolone—asthma	1.49e-05	9.06e-05	CcSEcCtD
Thalidomide—Diarrhoea—Hydrocortisone—asthma	1.47e-05	8.95e-05	CcSEcCtD
Thalidomide—Urticaria—Dexamethasone—asthma	1.46e-05	8.88e-05	CcSEcCtD
Thalidomide—Urticaria—Betamethasone—asthma	1.46e-05	8.88e-05	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Prednisone—asthma	1.46e-05	8.87e-05	CcSEcCtD
Thalidomide—Dizziness—Prednisolone—asthma	1.46e-05	8.86e-05	CcSEcCtD
Thalidomide—Asthenia—Triamcinolone—asthma	1.46e-05	8.84e-05	CcSEcCtD
Thalidomide—Body temperature increased—Betamethasone—asthma	1.46e-05	8.84e-05	CcSEcCtD
Thalidomide—Abdominal pain—Betamethasone—asthma	1.46e-05	8.84e-05	CcSEcCtD
Thalidomide—Abdominal pain—Dexamethasone—asthma	1.46e-05	8.84e-05	CcSEcCtD
Thalidomide—Body temperature increased—Dexamethasone—asthma	1.46e-05	8.84e-05	CcSEcCtD
Thalidomide—Asthenia—Methylprednisolone—asthma	1.45e-05	8.82e-05	CcSEcCtD
Thalidomide—Insomnia—Prednisone—asthma	1.45e-05	8.8e-05	CcSEcCtD
Thalidomide—Paraesthesia—Prednisone—asthma	1.44e-05	8.74e-05	CcSEcCtD
Thalidomide—Pruritus—Triamcinolone—asthma	1.44e-05	8.72e-05	CcSEcCtD
Thalidomide—Pruritus—Methylprednisolone—asthma	1.43e-05	8.7e-05	CcSEcCtD
Thalidomide—Dizziness—Hydrocortisone—asthma	1.43e-05	8.65e-05	CcSEcCtD
Thalidomide—Dyspepsia—Prednisone—asthma	1.41e-05	8.57e-05	CcSEcCtD
Thalidomide—Decreased appetite—Prednisone—asthma	1.39e-05	8.46e-05	CcSEcCtD
Thalidomide—Rash—Prednisolone—asthma	1.39e-05	8.45e-05	CcSEcCtD
Thalidomide—Dermatitis—Prednisolone—asthma	1.39e-05	8.44e-05	CcSEcCtD
Thalidomide—Diarrhoea—Methylprednisolone—asthma	1.39e-05	8.41e-05	CcSEcCtD
Thalidomide—Fatigue—Prednisone—asthma	1.38e-05	8.39e-05	CcSEcCtD
Thalidomide—Headache—Prednisolone—asthma	1.38e-05	8.39e-05	CcSEcCtD
Thalidomide—Constipation—Prednisone—asthma	1.37e-05	8.32e-05	CcSEcCtD
Thalidomide—Vomiting—Hydrocortisone—asthma	1.37e-05	8.32e-05	CcSEcCtD
Thalidomide—Rash—Hydrocortisone—asthma	1.36e-05	8.25e-05	CcSEcCtD
Thalidomide—Dermatitis—Hydrocortisone—asthma	1.36e-05	8.24e-05	CcSEcCtD
Thalidomide—Headache—Hydrocortisone—asthma	1.35e-05	8.2e-05	CcSEcCtD
Thalidomide—Dizziness—Triamcinolone—asthma	1.34e-05	8.15e-05	CcSEcCtD
Thalidomide—Dizziness—Methylprednisolone—asthma	1.34e-05	8.13e-05	CcSEcCtD
Thalidomide—Feeling abnormal—Prednisone—asthma	1.32e-05	8.02e-05	CcSEcCtD
Thalidomide—Asthenia—Betamethasone—asthma	1.32e-05	8.02e-05	CcSEcCtD
Thalidomide—Asthenia—Dexamethasone—asthma	1.32e-05	8.02e-05	CcSEcCtD
Thalidomide—Gastrointestinal pain—Prednisone—asthma	1.31e-05	7.96e-05	CcSEcCtD
Thalidomide—Nausea—Prednisolone—asthma	1.31e-05	7.96e-05	CcSEcCtD
Thalidomide—Pruritus—Betamethasone—asthma	1.3e-05	7.91e-05	CcSEcCtD
Thalidomide—Pruritus—Dexamethasone—asthma	1.3e-05	7.91e-05	CcSEcCtD
Thalidomide—Vomiting—Triamcinolone—asthma	1.29e-05	7.83e-05	CcSEcCtD
Thalidomide—Vomiting—Methylprednisolone—asthma	1.29e-05	7.81e-05	CcSEcCtD
Thalidomide—Nausea—Hydrocortisone—asthma	1.28e-05	7.77e-05	CcSEcCtD
Thalidomide—Rash—Triamcinolone—asthma	1.28e-05	7.77e-05	CcSEcCtD
Thalidomide—Dermatitis—Triamcinolone—asthma	1.28e-05	7.76e-05	CcSEcCtD
Thalidomide—Rash—Methylprednisolone—asthma	1.28e-05	7.75e-05	CcSEcCtD
Thalidomide—Dermatitis—Methylprednisolone—asthma	1.28e-05	7.74e-05	CcSEcCtD
Thalidomide—Urticaria—Prednisone—asthma	1.27e-05	7.73e-05	CcSEcCtD
Thalidomide—Headache—Triamcinolone—asthma	1.27e-05	7.72e-05	CcSEcCtD
Thalidomide—Headache—Methylprednisolone—asthma	1.27e-05	7.7e-05	CcSEcCtD
Thalidomide—Abdominal pain—Prednisone—asthma	1.27e-05	7.69e-05	CcSEcCtD
Thalidomide—Body temperature increased—Prednisone—asthma	1.27e-05	7.69e-05	CcSEcCtD
Thalidomide—Diarrhoea—Dexamethasone—asthma	1.26e-05	7.65e-05	CcSEcCtD
Thalidomide—Diarrhoea—Betamethasone—asthma	1.26e-05	7.65e-05	CcSEcCtD
Thalidomide—Dizziness—Betamethasone—asthma	1.22e-05	7.39e-05	CcSEcCtD
Thalidomide—Dizziness—Dexamethasone—asthma	1.22e-05	7.39e-05	CcSEcCtD
Thalidomide—Nausea—Triamcinolone—asthma	1.21e-05	7.32e-05	CcSEcCtD
Thalidomide—Nausea—Methylprednisolone—asthma	1.2e-05	7.3e-05	CcSEcCtD
Thalidomide—Hypersensitivity—Prednisone—asthma	1.18e-05	7.17e-05	CcSEcCtD
Thalidomide—Vomiting—Dexamethasone—asthma	1.17e-05	7.11e-05	CcSEcCtD
Thalidomide—Vomiting—Betamethasone—asthma	1.17e-05	7.11e-05	CcSEcCtD
Thalidomide—Rash—Dexamethasone—asthma	1.16e-05	7.05e-05	CcSEcCtD
Thalidomide—Rash—Betamethasone—asthma	1.16e-05	7.05e-05	CcSEcCtD
Thalidomide—Dermatitis—Dexamethasone—asthma	1.16e-05	7.04e-05	CcSEcCtD
Thalidomide—Dermatitis—Betamethasone—asthma	1.16e-05	7.04e-05	CcSEcCtD
Thalidomide—Headache—Dexamethasone—asthma	1.15e-05	7e-05	CcSEcCtD
Thalidomide—Headache—Betamethasone—asthma	1.15e-05	7e-05	CcSEcCtD
Thalidomide—Asthenia—Prednisone—asthma	1.15e-05	6.98e-05	CcSEcCtD
Thalidomide—Pruritus—Prednisone—asthma	1.13e-05	6.89e-05	CcSEcCtD
Thalidomide—Diarrhoea—Prednisone—asthma	1.1e-05	6.66e-05	CcSEcCtD
Thalidomide—Nausea—Dexamethasone—asthma	1.09e-05	6.64e-05	CcSEcCtD
Thalidomide—Nausea—Betamethasone—asthma	1.09e-05	6.64e-05	CcSEcCtD
Thalidomide—Dizziness—Prednisone—asthma	1.06e-05	6.44e-05	CcSEcCtD
Thalidomide—Vomiting—Prednisone—asthma	1.02e-05	6.19e-05	CcSEcCtD
Thalidomide—Rash—Prednisone—asthma	1.01e-05	6.14e-05	CcSEcCtD
Thalidomide—Dermatitis—Prednisone—asthma	1.01e-05	6.13e-05	CcSEcCtD
Thalidomide—Headache—Prednisone—asthma	1e-05	6.1e-05	CcSEcCtD
Thalidomide—Nausea—Prednisone—asthma	9.53e-06	5.78e-05	CcSEcCtD
Thalidomide—FGFR2—Disease—SERPINE1—asthma	5.04e-06	4.63e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PPP2CA—asthma	5.04e-06	4.63e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ALDH2—asthma	5.04e-06	4.63e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—BCL2—asthma	5.02e-06	4.61e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALOX5AP—asthma	5.01e-06	4.6e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALOX15—asthma	5.01e-06	4.6e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NOS1—asthma	4.99e-06	4.58e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IFNG—asthma	4.98e-06	4.57e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CARM1—asthma	4.97e-06	4.56e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—PDGFB—asthma	4.96e-06	4.56e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—ADCY2—asthma	4.95e-06	4.55e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCR5—asthma	4.95e-06	4.54e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALDH7A1—asthma	4.91e-06	4.51e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—DCN—asthma	4.89e-06	4.49e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL2RA—asthma	4.88e-06	4.48e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—RHOA—asthma	4.87e-06	4.47e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—C3—asthma	4.84e-06	4.44e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	4.83e-06	4.44e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NOS3—asthma	4.82e-06	4.42e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD4—asthma	4.81e-06	4.41e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—GSTT1—asthma	4.8e-06	4.41e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—GSTT1—asthma	4.79e-06	4.4e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CHAT—asthma	4.78e-06	4.39e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ALDH2—asthma	4.76e-06	4.37e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—LEP—asthma	4.74e-06	4.36e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ARG2—asthma	4.71e-06	4.33e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PDGFB—asthma	4.71e-06	4.32e-05	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—IL6—asthma	4.7e-06	4.32e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—asthma	4.7e-06	4.32e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1B—asthma	4.68e-06	4.3e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL2—asthma	4.66e-06	4.28e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—asthma	4.58e-06	4.2e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALOX5AP—asthma	4.57e-06	4.19e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALOX15—asthma	4.57e-06	4.19e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—GSTT1—asthma	4.53e-06	4.16e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—asthma	4.52e-06	4.15e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—LEP—asthma	4.5e-06	4.13e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—FN1—asthma	4.47e-06	4.11e-05	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—IL6—asthma	4.46e-06	4.1e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—GSTP1—asthma	4.45e-06	4.09e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1B—asthma	4.44e-06	4.08e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD4—asthma	4.44e-06	4.07e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL2—asthma	4.42e-06	4.06e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PTGS2—asthma	4.4e-06	4.05e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—HMOX1—asthma	4.39e-06	4.03e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—PTEN—asthma	4.39e-06	4.03e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ITPR1—asthma	4.38e-06	4.03e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CHAT—asthma	4.36e-06	4e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CAT—asthma	4.33e-06	3.98e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALOX5—asthma	4.26e-06	3.91e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—FN1—asthma	4.25e-06	3.9e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—NQO1—asthma	4.24e-06	3.89e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—asthma	4.17e-06	3.83e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—PTEN—asthma	4.16e-06	3.82e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—ITPR1—asthma	4.15e-06	3.82e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ADCY2—asthma	4.15e-06	3.81e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	4.13e-06	3.79e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—GSTM1—asthma	4.09e-06	3.76e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PLA2G4A—asthma	4.09e-06	3.76e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—POMC—asthma	4.08e-06	3.74e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CARM1—asthma	4.06e-06	3.73e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—IL6—asthma	4.06e-06	3.73e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—DCN—asthma	4e-06	3.68e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—NQO1—asthma	3.99e-06	3.67e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CCL2—asthma	3.99e-06	3.66e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—NQO1—asthma	3.98e-06	3.66e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6R—asthma	3.98e-06	3.65e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD86—asthma	3.96e-06	3.63e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—STAT3—asthma	3.92e-06	3.6e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ADCY2—asthma	3.91e-06	3.59e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALOX15—asthma	3.9e-06	3.58e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALOX5AP—asthma	3.9e-06	3.58e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ADCY2—asthma	3.9e-06	3.58e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALDH2—asthma	3.9e-06	3.58e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALOX5—asthma	3.88e-06	3.57e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—POMC—asthma	3.87e-06	3.55e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PTEN—asthma	3.84e-06	3.53e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCL2—asthma	3.78e-06	3.47e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6R—asthma	3.77e-06	3.46e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PPP2CA—asthma	3.77e-06	3.46e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—NQO1—asthma	3.76e-06	3.46e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	3.75e-06	3.44e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SMAD3—asthma	3.74e-06	3.43e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CHAT—asthma	3.72e-06	3.42e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—SERPINE1—asthma	3.72e-06	3.42e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—STAT3—asthma	3.72e-06	3.42e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GSTT1—asthma	3.71e-06	3.4e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CARM1—asthma	3.7e-06	3.4e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ADCY2—asthma	3.68e-06	3.38e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—DCN—asthma	3.65e-06	3.35e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.65e-06	3.35e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—RHOA—asthma	3.59e-06	3.3e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—asthma	3.59e-06	3.29e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PPP2CA—asthma	3.57e-06	3.28e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—EGFR—asthma	3.56e-06	3.27e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—NOS3—asthma	3.55e-06	3.26e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALDH2—asthma	3.55e-06	3.26e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—GSTP1—asthma	3.54e-06	3.25e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—SERPINE1—asthma	3.53e-06	3.24e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CCR5—asthma	3.51e-06	3.22e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—HMOX1—asthma	3.49e-06	3.2e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ITPR1—asthma	3.48e-06	3.2e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CAT—asthma	3.44e-06	3.16e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—STAT3—asthma	3.44e-06	3.16e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	3.42e-06	3.14e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	3.41e-06	3.14e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RHOA—asthma	3.41e-06	3.13e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—EGFR—asthma	3.38e-06	3.11e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GSTT1—asthma	3.38e-06	3.1e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NOS3—asthma	3.37e-06	3.1e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PDGFB—asthma	3.34e-06	3.07e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—GSTP1—asthma	3.33e-06	3.06e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—GSTP1—asthma	3.32e-06	3.05e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALOX5—asthma	3.32e-06	3.05e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—HMOX1—asthma	3.28e-06	3.01e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—HMOX1—asthma	3.28e-06	3.01e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ITPR1—asthma	3.28e-06	3.01e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ITPR1—asthma	3.27e-06	3e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PLA2G4A—asthma	3.25e-06	2.98e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—GSTM1—asthma	3.25e-06	2.98e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CAT—asthma	3.24e-06	2.97e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CAT—asthma	3.23e-06	2.97e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TGFB1—asthma	3.18e-06	2.92e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—asthma	3.18e-06	2.92e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CARM1—asthma	3.17e-06	2.91e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL8—asthma	3.15e-06	2.9e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—GSTP1—asthma	3.14e-06	2.88e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—EGFR—asthma	3.12e-06	2.87e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—DCN—asthma	3.12e-06	2.87e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	3.11e-06	2.86e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—HMOX1—asthma	3.1e-06	2.84e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ITPR1—asthma	3.09e-06	2.84e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—NQO1—asthma	3.08e-06	2.83e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PLA2G4A—asthma	3.06e-06	2.81e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—GSTM1—asthma	3.06e-06	2.81e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CAT—asthma	3.05e-06	2.8e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—GSTM1—asthma	3.05e-06	2.8e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PLA2G4A—asthma	3.05e-06	2.8e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALDH2—asthma	3.04e-06	2.79e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ADCY2—asthma	3.01e-06	2.77e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL2—asthma	3.01e-06	2.77e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PPP2CA—asthma	2.99e-06	2.75e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL8—asthma	2.99e-06	2.75e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.99e-06	2.74e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NOS2—asthma	2.98e-06	2.73e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	2.92e-06	2.68e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—POMC—asthma	2.89e-06	2.66e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GSTT1—asthma	2.89e-06	2.65e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PLA2G4A—asthma	2.88e-06	2.65e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—GSTM1—asthma	2.88e-06	2.65e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL2—asthma	2.86e-06	2.63e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP9—asthma	2.85e-06	2.62e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—PTEN—asthma	2.84e-06	2.6e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PPP2CA—asthma	2.82e-06	2.59e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PPP2CA—asthma	2.81e-06	2.58e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—NQO1—asthma	2.81e-06	2.58e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ADCY2—asthma	2.75e-06	2.52e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL6—asthma	2.74e-06	2.52e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.72e-06	2.5e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP9—asthma	2.71e-06	2.48e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PTEN—asthma	2.69e-06	2.47e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6R—asthma	2.68e-06	2.46e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	2.66e-06	2.44e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PPP2CA—asthma	2.66e-06	2.44e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ALB—asthma	2.64e-06	2.42e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	2.61e-06	2.39e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL6—asthma	2.6e-06	2.39e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GSTP1—asthma	2.57e-06	2.36e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—VEGFA—asthma	2.56e-06	2.35e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—STAT3—asthma	2.54e-06	2.33e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—HMOX1—asthma	2.53e-06	2.33e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ITPR1—asthma	2.53e-06	2.32e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—NOS3—asthma	2.52e-06	2.32e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SERPINE1—asthma	2.51e-06	2.3e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CAT—asthma	2.5e-06	2.3e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—VEGFA—asthma	2.43e-06	2.23e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—RHOA—asthma	2.42e-06	2.22e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—STAT3—asthma	2.41e-06	2.21e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IL6—asthma	2.4e-06	2.2e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—NQO1—asthma	2.4e-06	2.2e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NOS3—asthma	2.39e-06	2.2e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	2.38e-06	2.18e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PLA2G4A—asthma	2.36e-06	2.17e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GSTM1—asthma	2.36e-06	2.17e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TGFB1—asthma	2.35e-06	2.16e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ADCY2—asthma	2.35e-06	2.16e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GSTP1—asthma	2.34e-06	2.15e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.33e-06	2.14e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—HMOX1—asthma	2.31e-06	2.12e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTGS2—asthma	2.31e-06	2.12e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—EGFR—asthma	2.3e-06	2.12e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ITPR1—asthma	2.3e-06	2.12e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—POMC—asthma	2.3e-06	2.11e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CAT—asthma	2.28e-06	2.09e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TGFB1—asthma	2.23e-06	2.05e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD4—asthma	2.2e-06	2.02e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—EGFR—asthma	2.19e-06	2.01e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PPP2CA—asthma	2.17e-06	2e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—POMC—asthma	2.16e-06	1.99e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—POMC—asthma	2.16e-06	1.98e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GSTM1—asthma	2.15e-06	1.98e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PLA2G4A—asthma	2.15e-06	1.98e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ALB—asthma	2.09e-06	1.92e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—POMC—asthma	2.04e-06	1.87e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	2.03e-06	1.86e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTEN—asthma	2.01e-06	1.85e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—NOS3—asthma	2e-06	1.84e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GSTP1—asthma	2e-06	1.84e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PPP2CA—asthma	1.98e-06	1.82e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—HMOX1—asthma	1.97e-06	1.81e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ALB—asthma	1.97e-06	1.81e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ITPR1—asthma	1.97e-06	1.81e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ALB—asthma	1.97e-06	1.81e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CAT—asthma	1.95e-06	1.79e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PTEN—asthma	1.91e-06	1.75e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—NOS3—asthma	1.89e-06	1.73e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—NOS3—asthma	1.88e-06	1.73e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ALB—asthma	1.86e-06	1.71e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PLA2G4A—asthma	1.84e-06	1.69e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GSTM1—asthma	1.84e-06	1.69e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—NOS3—asthma	1.78e-06	1.63e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6—asthma	1.77e-06	1.63e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGS2—asthma	1.72e-06	1.58e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGS2—asthma	1.72e-06	1.58e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—STAT3—asthma	1.71e-06	1.57e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PPP2CA—asthma	1.69e-06	1.56e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6—asthma	1.68e-06	1.54e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—POMC—asthma	1.67e-06	1.53e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGS2—asthma	1.63e-06	1.49e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PTEN—asthma	1.6e-06	1.47e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TGFB1—asthma	1.58e-06	1.45e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—EGFR—asthma	1.55e-06	1.42e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—POMC—asthma	1.52e-06	1.4e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALB—asthma	1.52e-06	1.4e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTEN—asthma	1.5e-06	1.38e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTEN—asthma	1.5e-06	1.38e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—NOS3—asthma	1.45e-06	1.34e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTEN—asthma	1.42e-06	1.3e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALB—asthma	1.39e-06	1.27e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGS2—asthma	1.33e-06	1.22e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—NOS3—asthma	1.33e-06	1.22e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—POMC—asthma	1.3e-06	1.19e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGS2—asthma	1.21e-06	1.11e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6—asthma	1.19e-06	1.09e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALB—asthma	1.19e-06	1.09e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTEN—asthma	1.16e-06	1.07e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—NOS3—asthma	1.13e-06	1.04e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTEN—asthma	1.06e-06	9.72e-06	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGS2—asthma	1.04e-06	9.52e-06	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTEN—asthma	9.04e-07	8.3e-06	CbGpPWpGaD
